01 September 2005
Hyperbaric oxygen and malignancies: a potential role in radiotherapy, chemotherapy,tumor surgery and phototherapy.
Noori S Al-Waili, Glenn J. Butler, Jorge Beale, Roger W. Hamilton, Bok Y. Lee, Paul LucasMed Sci Monit 2005; 11(9): RA279-289 :: ID: 428463
Abstract
Over the past 40 years, hyperbaric oxygen (HBO(2)) therapy has been recommendedand used in a wide variety of medical conditions. In the 1950s, HBO(2) was first used as a treatment,in addition to radiation, for head and neck cancers and cervical cancer. Many studies have been conductedto investigate possible therapeutic effects HBO(2) as part of cancer management. Evidences showed thatHBO(2) improved tumor oxygenation, and treatment with HBO(2) during irradiation has been shown to improvethe radiation response of many solid tumors. It was used for delayed radiation injuries for soft tissueand bony injuries, for symptomatic radiation reactions of the urinary bladder and the bowel, for laryngealradionecrosis, for radiation-induced optic neuropathy, for radiation-induced proctitis and for radiation-inducednecrosis of the brain. HBO(2) also increases sensitivity to chemotherapy. A significant improvement intumor response was obtained when photodynamic therapy (PDT) was delivered during hyperoxygenation. Thesestudies were extensively reviewed and rational scientific basis for further investigations was discussed.The possibility of combining HBO(2), PDT and photosezitizers to overcome primary and secondary carcinomadeserve extensive laboratory and clinical research works. HBO(2) is a relatively benign with few contraindications,even for active cancer patients.
Keywords: Combined Modality Therapy, Anoxia - therapy, Anemia - therapy, Hyperbaric Oxygenation, Neoplasms - therapy, Phototherapy, Radiation Injuries - therapy
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
14 Mar 2024 : Clinical Research
Renal Dysfunction Increases Risk of Adverse Cardiovascular Events in 5-Year Follow-Up Study of Intermediate...Med Sci Monit In Press; DOI: 10.12659/MSM.943956
15 Mar 2024 : Clinical Research
Impact of One-Lung Ventilation on Oxygenation and Ventilation Time in Thoracoscopic Heart Surgery: A Compar...Med Sci Monit In Press; DOI: 10.12659/MSM.943089
14 Mar 2024 : Clinical Research
Differential DHA and EPA Levels in Women with Preterm and Term Births: A Tertiary Hospital Study in IndonesiaMed Sci Monit In Press; DOI: 10.12659/MSM.943895
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952